Article

B+L voluntarily recalls eye vitamins

Bausch + Lomb (B+L) is voluntarily recalling an eye vitamin (PreserVision Eye Vitamin AREDS 2 Formula with Omega 3) after receiving ?a small number of reports predominantly within a specific age group, age 70 and older, who reported difficulty swallowing or a choking sensation when taking the soft gel,? according to the company.

Madison, NJ-Bausch + Lomb (B+L) is voluntarily recalling an eye vitamin (PreserVision Eye Vitamin AREDS 2 Formula with Omega 3) after receiving “a small number of reports predominantly within a specific age group, age 70 and older, [that] reported difficulty swallowing or a choking sensation when taking the soft gel,” according to the company.

The formulation, the only supplement being recalled by the company, is only available in the United States.

“To clarify, the formulation . . . is safe,” B+L officials said in a statement. “While many of our customers can comfortably swallow the supplement, we believe the design of the soft gel requires further consideration.”

The company plans to release the vitamin later this year in a smaller soft gel that will be dosed twice per day, two pills per dose.

B+L has notified retailers and eye-care professionals and is asking consumers to return the product to the company even if they find swallowing it comfortable. Consumers can call 800/553-5340 for instructions on returning and reimbursement. The customer service line is open 9 a.m. to 5 p.m. EST Monday through Friday.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
© 2025 MJH Life Sciences

All rights reserved.